Hemostatics

📍 Barcelona, Spain🗓 Founded 2020👥 6 employees
Hemostatics is developing a novel antifibrinolytic agent to reduce bleeding in life-threatening and disabling haemorrhagic conditions. Thanks to an innovative mechanism of action to inhibit fibrinolysis, our patented preclinical candidate is aiming to address a number of significant unmet medical needs in trauma, surgery, ICH, PPH, GI bleeding and in several bleeding disorders (Rare Diseases).
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Hemostatics founded?
Hemostatics was founded in 2020.
What industry is Hemostatics in?
Hemostatics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Hemostatics based?
Hemostatics is headquartered in Barcelona, Spain.